A feasibility study on two tailored interventions to improve adherence in adults with haemophilia.

Acceptance and commitment therapy Adherence Congenital disease Illness acceptance Lifelong treatment Self-management

Journal

Pilot and feasibility studies
ISSN: 2055-5784
Titre abrégé: Pilot Feasibility Stud
Pays: England
ID NLM: 101676536

Informations de publication

Date de publication:
01 Dec 2020
Historique:
received: 28 04 2020
accepted: 03 11 2020
entrez: 9 12 2020
pubmed: 10 12 2020
medline: 10 12 2020
Statut: epublish

Résumé

Haemophilia is a congenital bleeding disorder mainly affecting males. To prevent bleeding, patients need to perform regular intravenous injections (prophylaxis) throughout life. Non-adherence often occurs. Problems with acceptance or self-management appear to be the main reasons for non-adherence in haemophilia. The aim of this study was to test the feasibility and effects of two interventions focussed on acceptance (face-to-face) and self-management (online). Patients with severe haemophilia and acceptance or self-management problems were eligible. The face-to-face group intervention was based on Acceptance and Commitment Therapy (ACT) (8 sessions/6 months, target N = 8 participants). The online intervention was based on a successful online programme in rheumatoid arthritis (5-8 modules/2 months, target N = 8). Both interventions were designed according to the MRC framework in collaboration with the patient society and experts. We compared adherence (VERITAS-Pro, optimum 0), quality of life (SF-36, optimum 100) and illness perception (BIPQ, optimum 0) before start (T0) and after 2 months (T2). Feasibility criteria were as follows: completion of training by > 50% of participants and ability to collect at least 80% of outcome parameters. The face-to-face intervention was feasible (89% enrolment and recruitment, 100% retention). One hundred percent of the outcome parameters was collected. Results were promising: although adherence (VERITAS-Pro) was stable (from 64 to 62 points), quality of life (SF-36) showed a clinically relevant improvement (> 5 points) in five of eight domains. Illness perception (BIPQ) showed a clinically relevant increase from 47 to 39 points. Patient evaluation was positive. The online intervention, however, was infeasible: enrolment was only 20% (6/30). Only three patients signed informed consent (recruitment 10%), and none completed more than one module (retention 0%). Consequently, the online intervention was terminated. The face-to-face acceptance intervention was considered feasible with promising results. Unfortunately, the online intervention was infeasible and therefore terminated. These findings suggest that adapting effective interventions to other settings does not guarantee success, despite the use of established methodology and patient participation. Population differences (only male participants, congenital disease) could be an explanation for failure of the online intervention in haemophilia despite success in rheumatoid arthritis. NL55883.041.16.

Identifiants

pubmed: 33292771
doi: 10.1186/s40814-020-00723-w
pii: 10.1186/s40814-020-00723-w
pmc: PMC7708110
doi:

Types de publication

Journal Article

Langues

eng

Pagination

189

Subventions

Organisme : ZonMw
ID : 80-83600-98-3095
Pays : Netherlands

Références

Arthritis Rheum. 2007 Jan;56(1):199-207
pubmed: 17195222
AIDS Care. 2011 Dec;23(12):1660-7
pubmed: 21732897
Med Care. 1999 Jan;37(1):5-14
pubmed: 10413387
Haemophilia. 2001 Jul;7(4):392-6
pubmed: 11442644
J Psychosom Res. 2006 Jun;60(6):631-7
pubmed: 16731240
BMC Public Health. 2015 Jun 26;15:589
pubmed: 26112264
Pediatr Rheumatol Online J. 2017 Oct 13;15(1):75
pubmed: 29029616
Haemophilia. 2002 Nov;8(6):745-52
pubmed: 12410642
Patient Educ Couns. 2019 Sep;102(9):1722-1729
pubmed: 30982700
Thromb Haemost. 2016 May 2;115(5):931-8
pubmed: 26791021
Haemophilia. 2006 Jan;12(1):75-81
pubmed: 16409179
Diabetes Educ. 2007 May-Jun;33(3):465-74
pubmed: 17570877
Haemophilia. 2011 May;17(3):412-21
pubmed: 21332888
Biomed Res Int. 2015;2015:217047
pubmed: 26539470
Clin Psychol Rev. 2016 Jun;46:46-58
pubmed: 27176925
Ann Med. 2001 Jul;33(5):350-7
pubmed: 11491194
Clin Psychol Rev. 2001 Mar;21(2):205-40
pubmed: 11293366
Haemophilia. 2016 Jul;22(4):e311-4
pubmed: 27227699
Haemophilia. 2010 Mar;16(2):247-55
pubmed: 19925631
Psychosom Med. 2004 Jan-Feb;66(1):42-8
pubmed: 14747636
Blood Cells Mol Dis. 2017 Sep;67:81-85
pubmed: 28302350
BMC Public Health. 2009 Jun 30;9:213
pubmed: 19563685
Cochrane Database Syst Rev. 2020 Mar 18;3:CD010215
pubmed: 32187661
J Intern Med. 1992 Jul;232(1):25-32
pubmed: 1640190
Nurs Clin North Am. 2003 Sep;38(3):465-76, vi
pubmed: 14567203
Haemophilia. 2015 Sep;21(5):612-21
pubmed: 25858411
BMJ. 2008 Sep 29;337:a1655
pubmed: 18824488
JMIR Res Protoc. 2016 Jun 23;5(2):e113
pubmed: 27339472
Haemophilia. 2013 May;19(3):355-61
pubmed: 23279084
Haemophilia. 2006 Jan;12(1):47-51
pubmed: 16409174
Patient Educ Couns. 2007 May;66(2):192-201
pubmed: 17320338
BMJ. 1992 Jul 18;305(6846):160-4
pubmed: 1285753
BMC Nurs. 2015 Nov 19;14:61
pubmed: 26594131
Am J Prev Med. 2009 May;36(5):452-7
pubmed: 19362699
Behav Anal. 1994 Fall;17(2):289-303
pubmed: 22478193
Blood. 2004 Dec 1;104(12):3494-500
pubmed: 15308570
JMIR Res Protoc. 2015 Aug 14;4(3):e102
pubmed: 26276373
J Adv Nurs. 2004 Oct;48(1):84-92
pubmed: 15347414
Pilot Feasibility Stud. 2016 Oct 21;2:64
pubmed: 27965879
Br J Haematol. 2016 Aug;174(3):454-60
pubmed: 27098446

Auteurs

J W Hoefnagels (JW)

Division Internal Medicine and Dermatology, Van Creveldkliniek, University Medical Center Utrecht, PO Box 85500, 3508, GA, Utrecht, The Netherlands. J.W.Hoefnagels@umcutrecht.nl.

K Fischer (K)

Division Internal Medicine and Dermatology, Van Creveldkliniek, University Medical Center Utrecht, PO Box 85500, 3508, GA, Utrecht, The Netherlands.

R A T Bos (RAT)

Division Internal Medicine and Dermatology, Van Creveldkliniek, University Medical Center Utrecht, PO Box 85500, 3508, GA, Utrecht, The Netherlands.

M H E Driessens (MHE)

Netherlands Haemophilia Patient Society (NVHP), Nijkerk, The Netherlands.

S L A Meijer (SLA)

Netherlands Haemophilia Patient Society (NVHP), Nijkerk, The Netherlands.

R E G Schutgens (REG)

Division Internal Medicine and Dermatology, Van Creveldkliniek, University Medical Center Utrecht, PO Box 85500, 3508, GA, Utrecht, The Netherlands.

L H Schrijvers (LH)

Division Internal Medicine and Dermatology, Van Creveldkliniek, University Medical Center Utrecht, PO Box 85500, 3508, GA, Utrecht, The Netherlands.
Utrecht University of Applied Sciences, Utrecht, The Netherlands.

Classifications MeSH